5 SIMPLE STATEMENTS ABOUT DCK DRUG EXPLAINED

We subsequently made a far more specific probe, [18F]CFA, which was used in the current review to evaluate dCK activity in tumors when handled with a small molecule dCK inhibitor. This probe is also staying researched in a medical demo at our establishment to evaluate changes in dCK activity pursuing cancer immunotherapy 18. PET probes in preclinic